Studying the role of RANKL in breast cancer and bone metastasis mouse models

Studying the role of RANKL in breast cancer and bone metastasis mouse models

Bibliographic Details
Main Authors:	Evi Gkikopoulou, Anthi Kolokotroni, Vagelis Rinotas, Melina Dragolia, Vasileios Ntafis, Martina Rauner, Eleni Douni
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Bone Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352187221001558

Similar Items

Investigating Denosumab discontinuation in the TgRANKL osteoporotic mouse model
by: Vagelis Rinotas, et al.
Published: (2021-04-01)

RANKL promotes the expansion of mammary epithelial cells in osteoporotic TgRANKL mouse models
by: Anthi Kolokotroni, et al.
Published: (2020-10-01)

Establishment of progesterone-induced mammary carcinogenesis in a humanized TgRANKL osteoporotic mouse model
by: Anthi Kolokotroni, et al.
Published: (2020-10-01)

Α Humanized RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel Therapeutics
by: Anthi Kolokotroni, et al.
Published: (2023-08-01)

Bone remodeling mechanisms in osteoporotic TgRANKL transgenic mouse models
by: Vagelis Rinotas, et al.
Published: (2020-10-01)

Transcriptomic analysis in the TgRANKL mouse model of osteoporosis reveals miRNAs as potent regulators of bone remodeling
by: Elisavet Ioannidou, et al.
Published: (2021-04-01)

New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis
by: Maria Papadaki, et al.
Published: (2019-02-01)

In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
by: Georgia Melagraki, et al.
Published: (2018-07-01)

Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).
by: Georgia Melagraki, et al.
Published: (2017-04-01)

RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass
by: Nicolas Bonnet, et al.
Published: (2023-02-01)

Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis Inhibitors
by: Vagelis Rinotas, et al.
Published: (2023-07-01)

RANKL/OPG in Breast Cancer — Extending Its Territory to BRCA Mutation Carriers
by: Tilman D. Rachner, et al.
Published: (2015-10-01)

RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies
by: Xiaoqiu Wu, et al.
Published: (2020-02-01)

The role played by ailanthone in inhibiting bone metastasis of breast cancer by regulating tumor-bone microenvironment through the RANKL-dependent pathway
by: Yajun Wang, et al.
Published: (2023-01-01)

Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2
by: Fotini Filippopoulou, et al.
Published: (2021-12-01)

Roles of the RANKL–RANK Axis in Immunity—Implications for Pathogenesis and Treatment of Bone Metastasis
by: Bo Li, et al.
Published: (2022-03-01)

RANKL/RANK: from bone loss to the prevention of breast cancer
by: Verena Sigl, et al.
Published: (2016-01-01)

The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies
by: Yan Zhang, et al.
Published: (2022-12-01)

A splicing mutation in the novel mitochondrial protein DNAJC11 causes motor neuron pathology associated with cristae disorganization, and lymphoid abnormalities in mice.
by: Fotis Ioakeimidis, et al.
Published: (2014-01-01)

Inhibitory Effect of Chlorpromazine on RANKL-Induced Osteoclastogenesis in Mouse Bone Marrow Cells
by: Hiroharu Kawamura, et al.
Published: (2011-01-01)

RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway
by: Mineon Park, et al.
Published: (2021-06-01)

RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
by: Lau, Y, et al.
Published: (2007)

RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis
by: Zhiying Yue, et al.
Published: (2022-01-01)

RANK, RANKL and osteoprotegerin in arthritic bone loss
by: M.C. Bezerra, et al.
Published: (2005-02-01)

B-Cell RANKL Contributes to Pathogen-Induced Alveolar Bone Loss in an Experimental Periodontitis Mouse Model
by: Rajendra P. Settem, et al.
Published: (2021-09-01)

RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
by: Marco Infante, et al.
Published: (2019-01-01)

Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer.
by: Xianbo Peng, et al.
Published: (2013-01-01)

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
by: Aristofania Simatou, et al.
Published: (2020-10-01)

RANKL biology: bone metabolism, the immune system, and beyond
by: Takehito Ono, et al.
Published: (2020-02-01)

Metastasis of breast cancer to the bone
by: Joanna Wolska, et al.
Published: (2019-09-01)

Metastasis of breast cancer to the bone
by: Joanna Wolska, et al.
Published: (2019-09-01)

Bone metabolism and RANKL/RANK/OPG trail in periodontal disease
by: Czupkallo Lukasz, et al.
Published: (2016-12-01)

Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL
by: Yuria Jang, et al.
Published: (2021-01-01)

Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials
by: Junjie Lu, et al.
Published: (2023-02-01)

The Bone Morphogenetic Protein Pathway: The Osteoclastic Perspective
by: Franziska Lademann, et al.
Published: (2020-10-01)

NLRP3 Inflammasome Negatively Regulates RANKL-Induced Osteoclastogenesis of Mouse Bone Marrow Macrophages but Positively Regulates It in the Presence of Lipopolysaccharides
by: Mohammad Ibtehaz Alam, et al.
Published: (2022-05-01)

Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss.
by: Yoshiki Nakashima, et al.
Published: (2013-01-01)

Correction: Murrayanine suppresses the proliferation and metastasis of human breast cancer cells via induction of apoptosis and inhibition of RANK/RANKL signaling pathway
by: Jingnan Zhang, et al.
Published: (2023-08-01)

Ranking prognosis: Future perspective of RANK/RANKL in breast cancer
by: Ruby Dhar, et al.
Published: (2023-06-01)

Administration of RANKL boosts thymic regeneration upon bone marrow transplantation
by: Noella Lopes, et al.
Published: (2017-06-01)